Evolent Health Inc. (NYSE:EVH) CEO Frank J. Williams sold 251,481 shares of the stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $21.54, for a total transaction of $5,416,900.74. Following the transaction, the chief executive officer now owns 1,304,799 shares in the company, valued at $28,105,370.46. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of Evolent Health Inc. (NYSE:EVH) opened at 22.71 on Tuesday. The company’s market capitalization is $1.37 billion. Evolent Health Inc. has a 12 month low of $8.14 and a 12 month high of $26.84. The company has a 50-day moving average of $24.35 and a 200 day moving average of $17.14.

Evolent Health (NYSE:EVH) last issued its quarterly earnings data on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.04. Evolent Health had a negative net margin of 76.55% and a negative return on equity of 5.04%. The business earned $56.50 million during the quarter, compared to analysts’ expectations of $51.96 million. During the same period in the previous year, the company earned ($0.95) earnings per share. Evolent Health’s revenue for the quarter was up 443.3% on a year-over-year basis. Analysts forecast that Evolent Health Inc. will post ($0.54) EPS for the current year.

Several hedge funds have recently modified their holdings of EVH. FMR LLC boosted its stake in shares of Evolent Health by 11.3% in the second quarter. FMR LLC now owns 1,865,791 shares of the company’s stock worth $35,823,000 after buying an additional 189,612 shares during the last quarter. Pennant Capital Management LLC boosted its stake in shares of Evolent Health by 54.2% in the first quarter. Pennant Capital Management LLC now owns 1,361,147 shares of the company’s stock worth $14,374,000 after buying an additional 478,318 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Evolent Health by 3.7% in the second quarter. JPMorgan Chase & Co. now owns 1,338,238 shares of the company’s stock worth $25,694,000 after buying an additional 47,773 shares during the last quarter. TimesSquare Capital Management LLC raised its position in shares of Evolent Health by 21.1% in the first quarter. TimesSquare Capital Management LLC now owns 1,192,755 shares of the company’s stock worth $12,595,000 after buying an additional 207,755 shares during the period. Finally, Vanguard Group Inc. raised its position in shares of Evolent Health by 7.7% in the second quarter. Vanguard Group Inc. now owns 1,015,527 shares of the company’s stock worth $19,499,000 after buying an additional 72,454 shares during the period. Institutional investors and hedge funds own 42.07% of the company’s stock.

EVH has been the topic of a number of recent research reports. Canaccord Genuity restated a “buy” rating and issued a $30.00 price target on shares of Evolent Health in a research report on Sunday, September 11th. Leerink Swann restated an “outperform” rating and issued a $20.00 price target on shares of Evolent Health in a research report on Sunday, July 17th. Jefferies Group initiated coverage on shares of Evolent Health in a research report on Tuesday, July 26th. They issued a “buy” rating and a $28.00 price target on the stock. Finally, FBR & Co raised their price target on shares of Evolent Health from $24.00 to $26.00 and gave the stock an “outperform” rating in a research report on Friday, August 5th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $22.50.

Evolent Health Company Profile

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

5 Day Chart for NYSE:EVH

Receive News & Ratings for Evolent Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.